Word

HELIX BIOTECH

Status

Pending

Status Code

661

Status Date

Monday, February 12, 2024

Serial Number

97792209

Mark Type

3000

Filing Date

Monday, February 13, 2023

Trademark Owner History

Helix Biotech, Inc

Classifications

42 Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples. LNP and Liposome Formulation, Manufacturing, and Analytical Services; Product development for others; Product research and development; Basic and clinical research in the field of respiratory science and medicine; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Consulting services in the field of product design and development; Design and testing for new product development; Executing of chemical analyses; Medical and scientific research, namely, conducting clinical trials for others; Performance of chemical analyses; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Testing, analysis and evaluation of leaf and petiole samples; Working on and evaluation of chemical analyses

The mark consists of the stylized wording "HELIX BIOTECH" and design. The letter "X" in "HELIX" is formed by a stylized DNA helix symbol. The term "HELIX" appears in a large font above the term "BIOTECH" which is centered below and appears in a small font.
Color is not claimed as a feature of the mark.
BIOTECH

Trademark Events

Feb 12, 2024

Teas/Email Correspondence Entered

Feb 12, 2024

Correspondence Received In Law Office

Feb 12, 2024

Teas Response To Office Action Received

Jan 8, 2024

Teas Change Of Correspondence Received

Jan 8, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Jan 8, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 15, 2023

Notification Of Non-Final Action E-Mailed

Nov 15, 2023

Non-Final Action E-Mailed

Nov 15, 2023

Non-Final Action Written

Nov 10, 2023

Assigned To Examiner

Mar 3, 2023

Notice Of Design Search Code E-Mailed

Mar 2, 2023

New Application Office Supplied Data Entered

Feb 16, 2023

New Application Entered